During the past decade, Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 2 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 2 clinical trials were completed. i.e. 4.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine" #1 sponsor was "Shanghai Jiao Tong University School of Medicine" with 19 trials, followed by "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University" with 14 trials sponsored, "Lifetech Scientific (Shenzhen) Co., Ltd." with 4 trials sponsored, "I-Mab Biopharma Co. Ltd." with 2 trials sponsored and "XiaoXi Lin" with 2 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine" #1 collaborator was "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University" with 7 trials as a collaborator, "RenJi Hospital" with 3 trials as a collaborator, "Shanghai Zhongshan Hospital" with 3 trials as a collaborator, "West China Hospital" with 3 trials as a collaborator and "Changhai Hospital" with 2 trials as a collaborator. Other collaborators include 138 different institutions and companies that were collaborators in the rest 137 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine" are "Oral Squamous Cell Carcinoma" (5 trials), "Carcinoma, Squamous Cell" (3 trials), "Head and Neck Squamous Cell Carcinoma" (3 trials), "Mouth Neoplasms" (3 trials) and "Oral Cancer" (3 trials). Many other conditions were trialed in "Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine" in a lesser frequency.

Most popular intervention types in "Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine" are "Drug" (36 trials), "Device" (22 trials), "Procedure" (13 trials), "Biological" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "TPF induction chemotherapy" (3 trials), "Camrelizumab" (2 trials), "Cisplatin" (2 trials) and "King Vision video laryngoscope" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine" are 78 trials for "All" genders.

Currently, there are 34 active trials in "Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine". 3 are not yet recruiting, 24 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine, 10 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 30 trials that are defined as “Not Applicable".